GeNeuro’s €7.7 Million Private Placement

McDermott Will & Emery advised GeNeuro on the deal.GeNeuro (Euronext Paris), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, announced its €7, 7 million…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Naoual Sadouqi

Author: Naoual Sadouqi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here